This action supports the policy priority to enhance crisis preparedness and response for future health emergencies in relation to medical countermeasures, with a focus on priority pathogens with pandemic potential. It implements the EU4Health Programme's general objective of improving the availability, accessibility and affordability of crisis-relevant products (Article 3, point (c)) through the specific objectives defined in Article 4, points (b) and (c), of Regulation (EU) 2021/522.

This action aims to create a European Hub for public health-relevant vaccine development, combining excellence in vaccine development with clinical trials and activities for scaling manufacturing. This call targets consortia of developers of vaccines coverin